Hepatorenal syndrome: emerging perspectives

Area of Science:

• Nephrology
• Hepatology
• Gastroenterology

Background:

• Hepatorenal syndrome is a severe complication of advanced liver disease, characterized by functional renal failure with minimal kidney pathology.
• Despite poor prognosis, kidneys in hepatorenal syndrome patients can function normally post-transplant, indicating reversibility.

Purpose of the Study:

• To review recent advancements in understanding the pathophysiology of hepatorenal syndrome.
• To discuss emerging therapeutic strategies for managing this condition.

Main Methods:

• Review of current literature on hepatorenal syndrome pathophysiology and treatment.
• Analysis of new methodologies like tracer kinetics and pathway characterization (endothelin, nitric oxide-arginine).

Main Results:

• Hepatorenal syndrome exhibits distinct renal function alterations: hyperosmolar urine, high urine to plasma creatinine ratio, and low urine sodium.
• Sympathetic nervous system activation, endothelin, and nitric oxide pathways are implicated in its pathogenesis.
• Nitric oxide may mediate hyperdynamic circulation and renal failure.

Conclusions:

• Emerging therapies, including orthotopic liver transplantation and transjugular intrahepatic porto-systemic shunt, offer optimism for hepatorenal syndrome management.
• Ongoing trials aim to define the roles of these treatments in improving renal function and patient outcomes.